Faster access to better and safer medicines

A potential drawback of clinical trials of new drugs is that they do not always reflect how well these will work in the 'real world'. EU and industry-funded research brought together key stakeholders to help add more such evidence into the design of trials, increasing confidence in new medicines and helping to get them to patients more quickly.
Source: EUROPA - Research Information Centre - Category: Research Source Type: news